Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) fell 17.6% during mid-day trading on Tuesday. The company traded as low as C$4.40 and last traded at C$4.53. Approximately 5,325 shares traded hands during trading, an increase of 44% from the average session volume of 3,686 shares. The stock had previously closed at C$5.50.
Genscript Biotech Trading Down 10.6%
The stock has a fifty day moving average price of C$4.43 and a two-hundred day moving average price of C$2.61.
Genscript Biotech Company Profile
GenScript Biotech Corporation is a biotechnology company that provides research and development services, biological products, and manufacturing support to pharmaceutical and biotechnology companies, academic institutions, and other organizations. The company’s offerings are designed to support work in areas including drug discovery, gene and cell therapy, immunotherapy, and synthetic biology.
Its life sciences services include gene synthesis, oligonucleotide production, molecular biology services, protein and antibody development, peptide synthesis, and cell and gene engineering.
Featured Articles
- Five stocks we like better than Genscript Biotech
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
